pMMR/MSS Locally Advanced Rectal Cancer Clinical Trials in Guangzhou, Guangdong

Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK）